MDCO : Analysis & Opinions

  1. FDA Accepts The Medicines Co.'s NDA - Analyst Blog

    July 5, 2013
    A response on the Cangrelor NDA should be out in the second quarter of 2014.
  2. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  3. MDCO-BMY Deal Comes into Effect - Analyst Blog

    February 11, 2013
    The Medicines Company (MDCO) recently announced that its two-year global collaboration agreement for Recothrom with Bristol-Myers ...
  4. Positive Results on MDCO's Cangrelor - Analyst Blog

    January 10, 2013
    The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III candidate, ...
  5. MDCO Scores in SOLO-1 Trial - Analyst Blog

    December 24, 2012
    The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III antibiotic ...
  6. Nasdaq Stocks, Including Bed Bath & Beyond, Making Big Moves ...

    December 20, 2012
    Currently, the Nasdaq is trading down 0.4%, the S&P 500 is unchanged and the Dow has declined 0.1%. The Nasdaq Composite ...
  7. Merck and More Big Movers in Healthcare on December 20, 2012

    December 20, 2012
    The Nasdaq is down 0.4%, the S&P 500 remains relatively unchanged and the Dow has decreased 0.1% after the morning's trading. ...
  8. The Medicines Co. Strikes Two Deals - Analyst Blog

    December 18, 2012
    The Medicines Company (MDCO) recently signed two agreements in a bid to boost its top line. While one agreement relates to ...
  9. Medivation and Other Big Movers In Healthcare on December 3, ...

    December 3, 2012
    After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. The healthcare ...
  10. Revs Up at The Medicines Company - Analyst Blog

    October 25, 2012
    The Medicines Company (MDCO) reported third quarter earnings of 32 cents per share, well above the year-ago earnings of 12 ...
  11. The Medicines Co. Halts MDCO-2010 - Analyst Blog

    October 8, 2012
    The Medicines Company (MDCO) recently discontinued an ongoing study being conducted with its phase II pipeline candidate ...
  12. Nasdaq Stocks, Including Dollar Tree, Making Big Moves on October ...

    October 5, 2012
    This morning has been good for the market, with the Nasdaq climbing 0.2%, the S&P 500 up 0.5% and the Dow increasing 0.5%. ...
  13. Thermo Fisher and More Big Movers in Healthcare on October 5, ...

    October 5, 2012
    The market has been doing well after the morning's trading. The Nasdaq has climbed 0.2%; the S&P 500 has increased 0.5%; ...
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center